{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:38:08Z","timestamp":1790872688928,"version":"4.1.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Parasites of the phylum Apicomplexa impact humans in nearly all parts of the world, causing diseases including to toxoplasmosis, cryptosporidiosis, babesiosis, and malaria. Apicomplexan parasites have complex life cycles comprised of one or more stages characterized by rapid replication and biomass amplification, which enables accelerated evolutionary adaptation to environmental changes, including to drug pressure. The emergence of drug resistant pathogens is a major looming and\/or active threat for current frontline chemotherapies, especially for widely used antimalarial drugs. In fact, resistant parasites have been reported against all modern antimalarial drugs within 15 years of clinical introduction, including the current frontline artemisinin-based combination therapies. Chemotherapeutics are a major tool in the public health arsenal for combatting the onset and spread of apicomplexan diseases. All currently approved antimalarial drugs have been discovered either through chemical modification of natural products or through large-scale screening of chemical libraries for parasite death phenotypes, and so far, none have been developed through a gene-to-drug pipeline. However, the limited duration of efficacy of these drugs in the field underscores the need for new and innovative approaches to discover drugs that can counter rapid resistance evolution. This review details both historical and current antimalarial drug discovery approaches. We also highlight new strategies that may be employed to discover resistance-resistant drug targets and chemotherapies in order to circumvent the rapid evolution of resistance in apicomplexan parasites.<\/jats:p>","DOI":"10.3389\/fcimb.2021.691121","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:26:40Z","timestamp":1623410800000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Re-Envisioning Anti-Apicomplexan Parasite Drug Discovery Approaches"],"prefix":"10.3389","volume":"11","author":[{"given":"Gabriel W.","family":"Rangel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Llin\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acsinfecdis.9b00482","article-title":"Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials","volume":"6","author":"Abraham","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an Old Anti-Malarial Drug in a Modern World: Role in the Treatment of Malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","article-title":"Origins of the Current Outbreak of Multidrug-Resistant Malaria in Southeast Asia: A Retrospective Genetic Study","volume":"18","author":"Amato","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"eaat9446","DOI":"10.1126\/science.aat9446","article-title":"Open-Source Discovery of Chemical Leads for Next-Generation Chemoprotective Antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"key":"B5","author":"Benazet","year":"1965"},{"key":"B6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/177815a0","article-title":"Perkin and the Dyestuffs Industry in Britain","volume":"177","author":"Brightman","year":"1956","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/2049-9957-3-9","article-title":"Development of Antimalarial Drugs and Their Application in China: A Historical Review","volume":"3","author":"Chen","year":"2014","journal-title":"Infect. Dis. Poverty"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1021\/acs.jmedchem.9b00182","article-title":"Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues","volume":"62","author":"Cheviet","year":"2019","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4269\/ajtmh.1963.12.121","article-title":"Pitfalls in a Discovery: The Chronicle of Chloroquine *","volume":"12","author":"Coatney","year":"1963","journal-title":"Am. J. Trop. Med. Hygiene"},{"key":"B10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3181\/00379727-72-17506","article-title":"Antimalarial Activity of Aureomycin Against Plasmodium Gallinaceum in the Chick","volume":"72","author":"Coatney","year":"1949","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3181\/00379727-38-10010","article-title":"Prophylactic and Therapeutic Effect of Sulfonamide Compounds in Experimental Malaria","volume":"38","author":"Coggeshall","year":"1938","journal-title":"Exp. Biol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1021\/jm00277a018","article-title":"Antimalarial Arylaminopropanols","volume":"15","author":"Colwell","year":"1972","journal-title":"J. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13073-019-0673-3","article-title":"Advances in Omics-Based Methods to Identify Novel Targets for Malaria and Other Parasitic Protozoan Infections","volume":"11","author":"Cowell","year":"2019","journal-title":"Genome Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, Mechanisms of Action and Combination Therapy of Artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/00034983.1945.11685229","article-title":"Studies on Synthetic Antimalarial Drugs: II.\u2014General Chemical Considerations","volume":"39","author":"Curd","year":"1945","journal-title":"Ann. Trop. Med. Parasitol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/00034983.1945.11685237","article-title":"Studies on Synthetic Antimalarial Drugs: X.\u2014Some Biguanide Derivatives as New Types of Antimalarial Substances With Both Therapeutic and Causal Prophylactic Activity","volume":"39","author":"Curd","year":"1945","journal-title":"Ann. Trop. Med. Parasitol"},{"key":"B17","first-page":"115","article-title":"The Causal Prophylactic Activity of the Novel Hydroxynaphthoquinone 566C80 Against Plasmodium Berghei Infections in Rats","volume":"58","author":"Davies","year":"1989","journal-title":"Acta Leiden"},{"key":"B18","first-page":"874","article-title":"[Synthesis and Antimalarial Activities of Fluorenemethanols]","volume":"32","author":"Deng","year":"1997","journal-title":"Yao Xue Xue Bao"},{"key":"B19","first-page":"953","article-title":"Ueber Die Wirkung Des Methylenblau Bei Malaria","volume":"28","author":"Ehrlich","year":"1891","journal-title":"Berliner klinische Wochhenschrift"},{"key":"B20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1476-5381.1951.tb00634.x","article-title":"2:4-Diaminopyrimidines- a New Series of Antimalarials","volume":"6","author":"Falco","year":"1951","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of Chemical Starting Points for Antimalarial Lead Identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2307\/3281373","article-title":"An In Vitro Assay System for the Identification of Potential Antimalarial Drugs","volume":"69","author":"Geary","year":"1983","journal-title":"J. Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical Genetics of Plasmodium Falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/263767a0","article-title":"Culture of Human Malaria Parasites Plasmodium Falciparum","volume":"263","author":"Haynes","year":"1976","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9258(18)56438-3","article-title":"Antagonists OF Nucleic ACID Derivatives","volume":"183","author":"Hitchings","year":"1950","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"204ra132","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Sci. Trans. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4269\/ajtmh.1992.47.378","article-title":"Activity of Azithromycin (CP-62,993) and Erythromycin Against Chloroquine-Sensitive and Chloroquine-Resistant Strains of Plasmodium Falciparum In Vitro","volume":"47","author":"Jensen","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1128\/AAC.49.3.1169-1176.2005","article-title":"Antimalarial Activities and Therapeutic Properties of Febrifugine Analogs","volume":"49","author":"Jiang","year":"2005","journal-title":"AAC"},{"key":"B29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nchembio.87","article-title":"Gene Expression Signatures and Small-Molecule Compounds Link a Protein Kinase to Plasmodium Falciparum Motility","volume":"4","author":"Kato","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpara.2018.09.005","article-title":"To Kill a Piroplasm: Genetic Technologies to Advance Drug Discovery and Target Identification in Babesia","volume":"49","author":"Keroack","year":"2019","journal-title":"Int. J. Parasitol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e758","DOI":"10.1016\/S2214-109X(18)30283-3","article-title":"Morbidity, Mortality, and Long-Term Consequences Associated With Diarrhoea From Cryptosporidium Infection in Children Younger Than 5 Years: A Meta-Analyses Study","volume":"6","author":"Khalil","year":"2018","journal-title":"Lancet Glob. Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1055\/s-0028-1122899","article-title":"Zur Weiterentwicklung Synthetisch Dargestellter Malariamittel","volume":"58","author":"Kikuth","year":"1932","journal-title":"Dtsch Med. Wochenschr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/ja01199a513","article-title":"An ALKALOID With HIGH Antimalarial ACTIVITY From DICHROA Febrifuga1","volume":"69","author":"Koepfli","year":"1947","journal-title":"J. Am. Chem. Soc."},{"key":"B34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bfgp\/elz012","article-title":"Cutting Back Malaria: CRISPR\/Cas9 Genome Editing of Plasmodium","volume":"18","author":"Lee","year":"2019","journal-title":"Brief Funct. Genomics"},{"key":"B35","first-page":"537","article-title":"Antiplasmodial Activity of Halogenated Lincomycin Analogues in Plasmodium Berghei-Infected Mice","volume":"7","author":"Lewis","year":"1967","journal-title":"Antimicrob. Agents Chemother. (Bethesda)"},{"key":"B36","first-page":"77","article-title":"[Studies on Antimalarials Synthesis of 4-Arylamino-Tert-Butylaminomethyl Phenols (Author\u2019s Transl)]","volume":"17","author":"Li","year":"1982","journal-title":"Yao Xue Xue Bao"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","article-title":"Activity of A New Antimalarial Agent, Chloroquine (Sn 7618): Statement Approved by the Board for Coordination of Malarial Studies","volume":"130","author":"Loeb","year":"1946","journal-title":"JAMA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1073\/pnas.1320886110","article-title":"Harnessing Evolutionary Fitness in Plasmodium Falciparum for Drug Discovery and Suppressing Resistance","volume":"111","author":"Lukens","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in Vitro Evolution and Whole Genome Analysis (IVIEWGA) to Discover Next Generation Targets for Antimalarial Drug Discovery","volume":"4","author":"Luth","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B40","first-page":"1056","article-title":"Lincomycin: A New Antibiotic Active Against Staphylococci and Other Gram-Positive Cocci: Clinical and Labaratory Studies","volume":"91","author":"Macleod","year":"1964","journal-title":"Can. Med. Assoc. J."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.1861","article-title":"A Theoretical Examination of the Relative Importance of Evolution Management and Drug Development for Managing Resistance","volume":"281","author":"McClure","year":"2014","journal-title":"Proc. Biol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to Eliminate Malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"B43","unstructured":"MMV at a Glance: Toward a Malaria-Free World2020"},{"key":"B44","unstructured":"Mmv Open2021"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug Resistance in Toxoplasma Gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41467-018-08098-6","article-title":"Antibiotic Collateral Sensitivity Is Contingent on the Repeatability of Evolution","volume":"10","author":"Nichol","year":"2019","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molbiopara.2010.09.001","article-title":"Central Carbon Metabolism of Plasmodium Parasites","volume":"175","author":"Olszewski","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"431\u2013434","DOI":"10.1021\/jm00315a031","article-title":"2,4,7-Triamino-6- Ortho -Substituted Arylpteridines. A New Series of Potent Antimalarial Agents","volume":"10","author":"Osdene","year":"1967","journal-title":"J. Med. Chem"},{"key":"B50","first-page":"337","article-title":"Recherches Chimiques Sur Les Quinquinas","author":"Pelletier","year":"1820","journal-title":"Ann. Chim. Phys."},{"key":"B51","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In Silico Activity Profiling Reveals the Mechanism of Action of Antimalarials Discovered in a High-Throughput Screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"PNAS"},{"key":"B52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral Sensitivity as a Strategy Against Cancer Multidrug Resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"B53","first-page":"811","article-title":"Antimalaria Studies on Qinghaosu","volume":"92","year":"1979","journal-title":"Chin. Med. J. (Engl.)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/BF01451737","article-title":"Die Wirkung Des Plasmochins Auf Die Vogelmalaria","volume":"14","author":"Roehl","year":"1926","journal-title":"Die Naturwissenschaften"},{"key":"B55","unstructured":". Drug Evaluation in the Plasmodium Falciparum\n            RossanR. N.\n          Aotus Model. Annual and Final Report for the Period 1 July 1976 to 15 July 1984. U.S. Army Medical Research and Development Command1984"},{"key":"B56","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/acsinfecdis.7b00217","article-title":"Identification of Collateral Sensitivity to Dihydroorotate Dehydrogenase Inhibitors in Plasmodium Falciparum","volume":"4","author":"Ross","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virol.2009.03.025","article-title":"Cholesterol Biosynthesis Modulation Regulates Dengue Viral Replication","volume":"389","author":"Rothwell","year":"2009","journal-title":"Virology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1009384","DOI":"10.1371\/journal.ppat.1009384","article-title":"Actives From MMV Open Access Boxes? A Suggested Way Forward","volume":"17","author":"Samby","year":"2021","journal-title":"PloS Pathog."},{"key":"B59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/0035-9203(73)90077-1","article-title":"Infections With Plasmodium Falciparum and Plasmodium Vivax in the Owl Monkey\u2013Model Systems for Basic Biological and Chemotherapeutic Studies","volume":"67","author":"Schmidt","year":"1973","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"B60","first-page":"125","article-title":"Avantages De La Quinisation Preventive Demontres Et Precises Experimentellement (Paludisme Des Oiseaux)","volume":"35","author":"Sergent","year":"1921","journal-title":"Annales l\u2019Institut Pasteur"},{"key":"B61","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1182\/blood-2014-04-567149","article-title":"Red Cells From Ferrochelatase-Deficient Erythropoietic Protoporphyria Patients Are Resistant to Growth of Malarial Parasites","volume":"125","author":"Smith","year":"2015","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","article-title":"The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The Malaria Parasite Cation ATPase PfATP4 and Its Role in the Mechanism of Action of a New Arsenal of Antimalarial Drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11427-015-4948-7","article-title":"The Discovery of Artemisinin and the Nobel Prize in Physiology or Medicine","volume":"58","author":"Su","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1128\/JB.64.4.489-499.1952","article-title":"Genetic Studies on Microbial Cross Resistance to Toxic Agents. I. Cross Resistance of Escherichia Coli to Fifteen Antibiotics","volume":"64","author":"Szybalski","year":"1952","journal-title":"J. Bacteriol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human Malaria Parasites in Continuous Culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and Clonal Expansion of In Vitro Artemisinin-Resistant Plasmodium Falciparum Kelch13 R561H Mutant Parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.chembiol.2020.04.001","article-title":"Inhibition of Resistance-Refractory P. Falciparum Kinase Pkg Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity","volume":"27","author":"Vanaerschot","year":"2020","journal-title":"Cell Chem. Biol"},{"key":"B69","unstructured":"WaletzkyE.\n            BerkelhammerG.\n            KantorS.\n          Method for Treating Coccidiosis With Quinazolinones1967"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","article-title":"Antimalarial Drug Resistance","volume":"113","author":"White","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B71","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1126\/science.aay5963","article-title":"A Roadmap for Malaria Research","volume":"365","author":"Winzeler","year":"2019","journal-title":"Science"},{"key":"B72","unstructured":"WiselogleF. Y.\n          A Survey of Antimalarial Drug 1941-1945. Edwards1946"},{"key":"B73","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","article-title":"Epidemiology of Drug-Resistant Malaria","volume":"2","author":"Wongsrichanalai","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"B74","volume-title":"Guidelines for the Treatment of Malaria","year":"2006"},{"key":"B75","volume-title":"World Malaria Report","year":"2019"},{"key":"B76","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.pt.2021.01.009","article-title":"MalDA, Accelerating Malaria Drug Discovery","volume":"37","author":"Yang","year":"2021","journal-title":"Trends Parasitol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"eaap7847","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the Essential Genes of the Human Malaria Parasite Plasmodium Falciparum by Saturation Mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"B78","first-page":"736","article-title":"Synthesis of 7351, A New Antimalarial Drug (Author\u2019s Transl)","volume":"14","author":"Zheng","year":"1979","journal-title":"Yao Xue Xue Bao"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","article-title":"Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects","volume":"16","author":"Zumla","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.691121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:26:55Z","timestamp":1623410815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2021.691121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":79,"alternative-id":["10.3389\/fcimb.2021.691121"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2021.691121","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"article-number":"691121"}}